“It has been postulated that the clinical benefit of adding POM results from enhanced immunocompetency.”

BUFFALO, NY - January 23, 2025 – A new editorial was published in Oncoscience's Volume 12 on January 14, 2025, titled, “Pomalidomide improved immune profiles in myeloma.”

The editorial by researchers Hannah Seah, Vaishnavi Reddy Bade, Lakshmi Bhavani Potluri, Srikanth Talluri, and Rao H. Prabhala from Dana-Farber Cancer Institute, VA Boston Healthcare System, and Harvard Medical